Validation of anti-aging drugs by treating age-related diseases

被引:122
作者
Blagosklonny, Mikhail V. [1 ]
机构
[1] Ordway Res Inst, Ctr Canc, Albany, NY 12208 USA
来源
AGING-US | 2009年 / 1卷 / 03期
关键词
Anti-aging drugs; diseases; cancer; atherosclerosis; resveratrol; rapamycin; metformin; SMALL-MOLECULE ACTIVATORS; AKT/PROTEIN KINASE-B; EXTENDS LIFE-SPAN; P70; S6; KINASE; CARDIAC-HYPERTROPHY; CALORIE RESTRICTION; MAMMALIAN TARGET; ALZHEIMERS-DISEASE; REDUCED INCIDENCE; KAPOSIS-SARCOMA;
D O I
10.18632/aging.100034
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Humans die from age-related diseases, which are deadly manifestations of the aging process. In order to extend-life span, an anti-aging drug must delay age-related diseases. All together age-related diseases are the best biomarker of aging. Once a drug is used for treatment of any one chronic disease, its effect against other diseases (atherosclerosis, cancer, prostate enlargement, osteoporosis, insulin resistance, Alzheimer's and Parkinson's diseases, age-related macular-degeneration) may be evaluated in the same group of patients. If the group is large, then the anti-aging effect could bevalidated in a couple of years. Startlingly, retrospective analysis of clinical and preclinical data reveals four potential anti-aging modalities.
引用
收藏
页码:281 / 288
页数:8
相关论文
共 107 条
[1]   Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease [J].
An, WL ;
Cowburn, RF ;
Li, L ;
Braak, H ;
Alafuzoff, I ;
Iqbal, K ;
Iqbal, IG ;
Winblad, B ;
Pei, JJ .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (02) :591-607
[2]   Metformin slows down aging and extends life span of female SHR mice [J].
Anisimov, Vladimir N. ;
Berstein, Lev M. ;
Egormin, Peter A. ;
Piskunova, Tatiana S. ;
Popovich, Irina G. ;
Zabezhinski, Mark A. ;
Tyndyk, Margarita L. ;
Yurova, Maria V. ;
Kovalenko, Irina G. ;
Poroshina, Tatiana E. ;
Semenchenko, Anna V. .
CELL CYCLE, 2008, 7 (17) :2769-2773
[3]   Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice [J].
Anisimov, VN ;
Egormin, PA ;
Bershtein, LM ;
Zabezhinskii, MA ;
Piskunova, TS ;
Popovich, IG ;
Semenchenko, AV .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 139 (06) :721-723
[4]  
ANISIMOV VN, 2006, CURR DRUG TARGETS, P7
[5]   Long-lived Klotho mice: new insights into the roles of IGF-1 and insulin-in aging [J].
Bartke, A .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2006, 17 (02) :33-35
[6]   Effect of Sirolimus on the cholesterol content of aortic arch in ApoE knockout mice [J].
Basso, MD ;
Nambi, P ;
Adelman, SJ .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (08) :3136-3138
[7]   An accelerated assay for the identification of lifespan-extending interventions in Drosophila melanogaster [J].
Bauer, JH ;
Goupil, S ;
Garber, GB ;
Helfand, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (35) :12980-12985
[8]   Resveratrol improves health and survival of mice on a high-calorie diet [J].
Baur, Joseph A. ;
Pearson, Kevin J. ;
Price, Nathan L. ;
Jamieson, Hamish A. ;
Lerin, Carles ;
Kalra, Avash ;
Prabhu, Vinayakumar V. ;
Allard, Joanne S. ;
Lopez-Lluch, Guillermo ;
Lewis, Kaitlyn ;
Pistell, Paul J. ;
Poosala, Suresh ;
Becker, Kevin G. ;
Boss, Olivier ;
Gwinn, Dana ;
Wang, Mingyi ;
Ramaswamy, Sharan ;
Fishbein, Kenneth W. ;
Spencer, Richard G. ;
Lakatta, Edward G. ;
Le Couteur, David ;
Shaw, Reuben J. ;
Navas, Placido ;
Puigserver, Pere ;
Ingram, Donald K. ;
de Cabo, Rafael ;
Sinclair, David A. .
NATURE, 2006, 444 (7117) :337-342
[9]   Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[10]   Rapamycin alleviates toxicity of different aggregate-prone proteins [J].
Berger, Z ;
Ravikumar, B ;
Menzies, FM ;
Oroz, LG ;
Underwood, BR ;
Pangalos, MN ;
Schmitt, I ;
Wullner, U ;
Evert, BO ;
O'Kane, CJ ;
Rubinsztein, DC .
HUMAN MOLECULAR GENETICS, 2006, 15 (03) :433-442